tiprankstipranks
Trending News
More News >
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market
Advertisement

Gyre Therapeutics (GYRE) Ratios

Compare
818 Followers

Gyre Therapeutics Ratios

GYRE's free cash flow for Q2 2025 was $0.96. For the 2025 fiscal year, GYRE's free cash flow was decreased by $ and operating cash flow was $0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.40 2.85 1.68 3.63 5.03
Quick Ratio
4.87 2.64 1.31 3.23 5.03
Cash Ratio
2.16 1.67 1.29 3.13 1.71
Solvency Ratio
0.44 -2.41 0.07 -6.01 -2.95
Operating Cash Flow Ratio
0.05 1.29 -1.97 -5.91 -3.09
Short-Term Operating Cash Flow Coverage
1.49 0.00 0.00 -42.36 -83.03
Net Current Asset Value
$ 68.08M$ 19.16M$ -21.93M$ 36.90M$ 70.73M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.04 0.02
Debt-to-Equity Ratio
0.02 -0.03 >-0.01 0.06 0.02
Debt-to-Capital Ratio
0.01 -0.03 >-0.01 0.05 0.02
Long-Term Debt-to-Capital Ratio
<0.01 0.00 0.00 0.00 0.01
Financial Leverage Ratio
1.66 -7.36 -1.31 1.35 1.25
Debt Service Coverage Ratio
19.63 0.00 13.92 -44.29 -85.48
Interest Coverage Ratio
0.00 0.00 -12.01- 0.00
Debt to Market Cap
<0.01 0.00 0.00 <0.01 <0.01
Interest Debt Per Share
0.02 <0.01 <0.01 0.08 0.09
Net Debt to EBITDA
-3.16 -1.63 -2.09 0.48 0.50
Profitability Margins
Gross Profit Margin
95.91%95.91%-0.50%-0.57%56.26%
EBIT Margin
9.14%16.94%1159.07%-1198.32%-268.48%
EBITDA Margin
10.86%17.92%1301.26%-1193.84%-273.87%
Operating Profit Margin
9.08%-59.26%-1084.51%-1197.79%-273.87%
Pretax Profit Margin
11.33%-67.84%-994.21%-1198.32%-268.48%
Net Profit Margin
7.87%-81.92%289.92%-1198.32%-265.14%
Continuous Operations Profit Margin
8.55%-75.35%543.32%-1198.32%-265.14%
Net Income Per EBT
69.50%120.75%-29.16%100.00%98.76%
EBT Per EBIT
124.81%114.48%91.67%100.04%98.03%
Return on Assets (ROA)
5.27%-79.74%8.09%-157.98%-58.56%
Return on Equity (ROE)
11.23%587.14%-10.61%-214.01%-73.02%
Return on Capital Employed (ROCE)
6.83%-69.67%-74.10%-211.81%-74.46%
Return on Invested Capital (ROIC)
7.45%-77.21%-74.23%-199.85%-72.91%
Return on Tangible Assets
5.45%-80.92%8.18%-251.97%-58.56%
Earnings Yield
1.17%-5.93%0.38%-21.02%-3.06%
Efficiency Ratios
Receivables Turnover
4.03 6.74 0.05 4.04 6.32
Payables Turnover
58.87 13.06 6.54 1.15 1.54
Inventory Turnover
0.47 1.08 0.13 1.29 9.16K
Fixed Asset Turnover
4.37 4.77 11.34 1.98 9.25
Asset Turnover
0.67 0.97 0.03 0.13 0.22
Working Capital Turnover Ratio
1.65 4.67 0.03 0.13 0.30
Cash Conversion Cycle
858.12 363.28 10.62K 55.84 -178.49
Days of Sales Outstanding
90.57 54.18 7.88K 90.43 57.73
Days of Inventory Outstanding
773.75 337.05 2.80K 282.88 0.04
Days of Payables Outstanding
6.20 27.95 55.80 317.47 236.26
Operating Cycle
864.32 391.23 10.68K 373.31 57.77
Cash Flow Ratios
Operating Cash Flow Per Share
0.01 0.39 -0.43 -2.73 -2.87
Free Cash Flow Per Share
>-0.01 0.26 -0.50 -2.76 -2.88
CapEx Per Share
0.01 0.13 0.07 0.03 0.01
Free Cash Flow to Operating Cash Flow
-0.09 0.67 1.15 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
0.92 0.11 -0.66 -99.83 -206.17
Capital Expenditure Coverage Ratio
0.92 3.02 -6.62 -99.83 -206.17
Operating Cash Flow Coverage Ratio
0.67 63.31 -870.95 -35.12 -33.48
Operating Cash Flow to Sales Ratio
<0.01 0.23 -41.68 -11.41 -2.63
Free Cash Flow Yield
-0.01%1.11%-6.24%-20.23%-3.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
85.41 -16.85 265.01 -4.76 -32.68
Price-to-Sales (P/S) Ratio
6.85 13.80 768.33 57.00 86.66
Price-to-Book (P/B) Ratio
7.47 -98.95 -28.13 10.18 23.86
Price-to-Free Cash Flow (P/FCF) Ratio
-8.86K 90.50 -16.01 -4.94 -32.82
Price-to-Operating Cash Flow Ratio
741.22 60.49 -18.43 -4.99 -32.98
Price-to-Earnings Growth (PEG) Ratio
-1.30 <0.01 -2.62 4.60 0.95
Price-to-Fair Value
7.47 -98.95 -28.13 10.18 23.86
Enterprise Value Multiple
59.90 75.42 56.95 -4.30 -31.14
Enterprise Value
664.66M 1.53B 588.42M 376.29M 1.79B
EV to EBITDA
59.90 75.42 56.95 -4.30 -31.14
EV to Sales
6.50 13.51 741.09 51.28 85.29
EV to Free Cash Flow
-8.41K 88.58 -15.45 -4.45 -32.30
EV to Operating Cash Flow
717.00 59.21 -17.78 -4.49 -32.46
Tangible Book Value Per Share
1.40 1.17 -0.29 0.66 3.97
Shareholders’ Equity Per Share
1.03 -0.24 -0.28 1.34 3.97
Tax and Other Ratios
Effective Tax Rate
-0.10 -0.11 -0.04 <0.01 0.01
Revenue Per Share
1.15 1.72 0.01 0.24 1.09
Net Income Per Share
0.09 -1.41 0.03 -2.87 -2.90
Tax Burden
0.70 1.21 -0.29 1.00 0.99
Interest Burden
1.24 -4.01 -0.86 1.00 1.00
Research & Development to Revenue
0.13 0.12 16.42 9.39 2.53
SG&A to Revenue
0.19 0.13 21.87 2.58 0.77
Stock-Based Compensation to Revenue
0.02 0.06 16.83 -0.04 0.17
Income Quality
0.13 -0.30 4.02 0.95 0.98
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis